Skip to main content

Advertisement

Log in

CircRNA: a rising therapeutic strategy for lung injury induced by pulmonary toxicants

  • Review Article
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Lung injury has been a serious medical problem that requires new therapeutic approaches and biomarkers. Circular RNAs (circRNAs) are non-coding RNAs (ncRNAs) that exist widely in eukaryotes. CircRNAs are single-stranded RNAs that form covalently closed loops. CircRNAs are significant gene regulators that have a role in the development, progression, and therapy of lung injury by controlling transcription, translating into protein, and sponging microRNAs (miRNAs) and proteins. Although the study of circRNAs in lung injury caused by pulmonary toxicants is just beginning, several studies have revealed their expression patterns. The function that circRNAs perform in relation to pulmonary toxicants (severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2), drug abuse, PM2.5, and cigarette smoke) is the main topic of this review. A variety of circRNAs can serve as potential biomarkers of lung injury. In this review, the biogenesis, properties, and biological functions of circRNAs were concluded, and the relationship between circRNAs and pulmonary toxicants was discussed. It is expected that the new ideas and potential treatment targets that circRNAs provide would be beneficial to research into the molecular mechanisms behind lung injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

Data sharing not applicable to this article as no datasets were generated during the current study.

References

Download references

Acknowledgements

This work is funded by the National Natural Science Foundation of China (No. 81973404) and Natural Science Foundation of Liaoning Province (No. 2022-MS-224).

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: CL, Z-WH, D-LK, and YW; writing––original draft preparation: CL and Z-WH; data analysis and literature search: RY, Y-JY, and X-RL; supervision and writing––review and editing: D-LK and YW; funding acquisition: YW. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to De-Lei Kong or Yun Wang.

Ethics declarations

Conflict of interest

The authors declare that there are no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liao, C., He, ZW., Yu, R. et al. CircRNA: a rising therapeutic strategy for lung injury induced by pulmonary toxicants. Arch Toxicol 98, 1297–1310 (2024). https://doi.org/10.1007/s00204-024-03706-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-024-03706-5

Keywords

Navigation